Sucralose increases hypothalamic activity linked to hunger more than sugar or water, especially in women and people with ...

Novo Nordisk has experienced a 50% drop due to potential tariffs and recent clinical trial results. Read why I rate NVO stock a strong buy right now.

New research indicates GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, ...

While it can affect your body differently when you have diabetes, sugar doesn’t have to be completely off the table.

A new study found that a popular zero-calorie sugar substitute disrupts regions of the brain responsible for regulating ...

Beta Bionics Inc.’s concept of an artificial pancreas that regulates blood sugar levels in people with type 1 diabetes (T1D) ...

Many individuals are told that managing type 2 diabetes is simply a matter of controlling blood sugar. As long as glucos ...

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Flavonoids show promise in treating type 2 diabetes mellitus by targeting the enteroendocrine system and regulating key gut ...

Compared to sugar, consuming sucralose—a widely used sugar substitute—increases activity in the hypothalamus, a brain region that regulates appetite and body weight, according to new USC research.

As a result, the pancreas compensates by producing more insulin, leading to hyperinsulinemia. Over time, this can contribute ...